| Heron Therapeutics (HRTX) | |||
|---|---|---|---|
| 3.57 0.35 (10.87%) | 08-08 16:00 | ||
| Open: | 3.33 | Pre. Close: | 3.22 |
| High: | 3.8 | Low: | 3.3 |
| Volume: | 4,565,380 | Market Cap: | 366M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 3.805 - 3.819 | 3.819 - 3.83 |
| Low: | 3.266 - 3.282 | 3.282 - 3.295 |
| Close: | 3.545 - 3.571 | 3.571 - 3.592 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 4.44  One year: 5.18 |
| Support: | Support1: 3.05 Support2: 2.58 |
| Resistance: | Resistance1: 3.80 Resistance2: 4.44 |
| Pivot: | 2.94 |
| Moving Averages: | MA(5): 3.09 MA(20): 2.95 MA(100): 3.86  MA(250): 7.30 |
| MACD: | MACD(12,26): 0.02 Signal(12,26,9): -0.05 |
| %K %D: | %K(14,3): 70.34 %D(3): 56.64 |
| RSI: | RSI(14): 66.66 |
| 52-Week: | High: 12.89 Low: 2.19 Change(%): -66.4 |
| Average Vol(K): | 3-Month: 2710 10-Days: 2717 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HRTX ] has closed above the upper band by 17.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 25% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Capital Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 102.48 |
| Shares Float (M) | 77.56 |
| % Held by Insiders | 0.24 |
| % Held by Institutions | 119.05 |
| Shares Short (K) | 40180 |
| Shares Short Prior Month (K) | 38980 |
| Stock Financials | |
|---|---|
| EPS | -2.293 |
| Book Value (p.s.) | 0.230 |
| Profit Margin | -258.35 |
| Operating Margin | -254.65 |
| Return on Assets (ttm) | -48.9 |
| Return on Equity (ttm) | -210.7 |
| Qtrly Rev. Growth | 17.2 |
| Gross Profit (p.s.) | -0.883 |
| Sales Per Share | 0.876 |
| EBITDA (p.s.) | -2.202 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -205.36 |
| Levered Free Cash Flow (M) | -102.33 |
| Stock Valuation | |
|---|---|
| PE Ratio | -1.56 |
| PEG Ratio | -0.03 |
| Price to Book value | 15.52 |
| Price to Sales | 4.07 |
| Price to Cash Flow | -1.78 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
